{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:19:06Z","timestamp":1791400746609,"version":"4.3.3"},"reference-count":35,"publisher":"e-Century Publishing Corporation","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/ttqj2494","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:28:32Z","timestamp":1756373312000},"page":"5885-5895","source":"Crossref","is-referenced-by-count":1,"title":["Baicalein inhibits DDX60 to suppress pancreatic cancer growth and regulate the tumor microenvironment"],"prefix":"10.62347","volume":"17","author":[{"given":"Lanying","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol 2021; 18: 493-502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"2129884","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic cancer: a review of current treatment and novel therapies","volume":"36","author":"Kolbeinsson","year":"2023","unstructured":"Kolbeinsson HM, Chandana S, Wright GP and Chung M. Pancreatic cancer: a review of current treatment and novel therapies. J Invest Surg 2023; 36: 2129884.","journal-title":"J Invest Surg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","article-title":"Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention","volume":"164","author":"EM","year":"2023","unstructured":"Stoffel EM, Brand RE and Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology 2023; 164: 752-765.","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis","volume":"520","author":"Cai","year":"2021","unstructured":"Cai J, Chen H, Lu M, Zhang Y, Lu B, You L, Zhang T, Dai M and Zhao Y. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett 2021; 520: 1-11.","journal-title":"Cancer Lett"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.2217\/fon-2021-0533","article-title":"Surgery for pancreatic cancer: current controversies and challenges","volume":"17","author":"Karunakaran","year":"2021","unstructured":"Karunakaran M and Barreto SG. Surgery for pancreatic cancer: current controversies and challenges. Future Oncol 2021; 17: 5135-5162.","journal-title":"Future Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"188868","DOI":"10.1016\/j.bbcan.2023.188868","article-title":"Liquid biopsy in pancreatic cancer - current perspective and future outlook","volume":"1878","author":"Zhao","year":"2023","unstructured":"Zhao Y, Tang J, Jiang K, Liu SY, Aicher A and Heeschen C. Liquid biopsy in pancreatic cancer - current perspective and future outlook. Biochim Biophys Acta Rev Cancer 2023; 1878: 188868.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"216031","DOI":"10.1016\/j.canlet.2022.216031","article-title":"Intratumoral microbiota: a new force in diagnosing and treating pancreatic cancer","volume":"554","author":"Jiang","year":"2023","unstructured":"Jiang Z, Zhang W, Zhang Z, Sha G, Wang D and Tang D. Intratumoral microbiota: a new force in diagnosing and treating pancreatic cancer. Cancer Lett 2023; 554: 216031.","journal-title":"Cancer Lett"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Yoon AR, Hong J, Jung BK, Ahn HM, Zhang S and Yun CO. Oncolytic adenovirus as pancreatic cancer-targeted therapy: where do we go from here? Cancer Lett 2023; 579: 216456.","DOI":"10.1016\/j.canlet.2023.216456"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"102719","DOI":"10.1016\/j.ctrv.2024.102719","article-title":"Pancreatic cancer biomarkers: a pathway to advance in personalized treatment selection","volume":"125","author":"Brozos-Vazquez","year":"2024","unstructured":"Brozos-Vazquez E, Toledano-Fonseca M, Costa-Fraga N, Garcia-Ortiz MV, Diaz-Lagares A, Rodriguez-Ariza A, Aranda E and Lopez-Lopez R. Pancreatic cancer biomarkers: a pathway to advance in personalized treatment selection. Cancer Treat Rev 2024; 125: 102719.","journal-title":"Cancer Treat Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.giec.2021.08.008","article-title":"Pancreatic cancer surveillance and novel strategies for screening","volume":"32","author":"Dudley","year":"2022","unstructured":"Dudley B and Brand RE. Pancreatic cancer surveillance and novel strategies for screening. Gastrointest Endosc Clin N Am 2022; 32: 13-25.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s11605-022-05553-0","article-title":"Pancreatic cancer: genetic conditions and epigenetic alterations","volume":"27","author":"Montalvo-Jave","year":"2023","unstructured":"Montalvo-Jave EE, Nuno-Lambarri N, Lopez-Sanchez GN, Ayala-Moreno EA, Gutierrez-Reyes G, Beane J and Pawlik TM. Pancreatic cancer: genetic conditions and epigenetic alterations. J Gastrointest Surg 2023; 27: 1001-1010.","journal-title":"J Gastrointest Surg"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Mazer BL, Lee JW, Roberts NJ, Chu LC, Lennon AM, Klein AP, Eshleman JR, Fishman EK, Canto MI, Goggins MG and Hruban RH. Screening for pancreatic cancer has the potential to save lives, but is it practical? Expert Rev Gastroenterol Hepatol 2023; 17: 555-574.","DOI":"10.1080\/17474124.2023.2217354"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"101234","DOI":"10.1016\/j.xcrm.2023.101234","article-title":"Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response","volume":"4","author":"Tang","year":"2023","unstructured":"Tang R, Xu J, Wang W, Meng Q, Shao C, Zhang Y, Lei Y, Zhang Z, Liu Y, Du Q, Sun X, Wu D, Liang C, Hua J, Zhang B, Yu X and Shi S; Chinese Study Group for Pancreatic Cancer. Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response. Cell Rep Med 2023; 4: 101234.","journal-title":"Cell Rep Med"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"van Dam JL, Janssen QP, Besselink MG, Homs MYV, van Santvoort HC, van Tienhoven G, de Wilde RF, Wilmink JW, van Eijck CHJ and Groot Koerkamp B; Dutch Pancreatic Cancer Group. Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomised controlled trials. Eur J Cancer 2022; 60: 140-149.","DOI":"10.1016\/j.ejca.2021.10.023"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.18632\/oncotarget.28242","article-title":"Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival","volume":"13","author":"Ulanja","year":"2022","unstructured":"Ulanja MB, Moody AE, Beutler BD, Antwi-Amoabeng D, Rahman GA and Alese OB. Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival. Oncotarget 2022; 13: 828-841.","journal-title":"Oncotarget"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/ans.16272","article-title":"Pancreatic cancer in the Australian population: identifying opportunities for intervention","volume":"90","author":"Barreto","year":"2020","unstructured":"Barreto SG and D’Onise K. Pancreatic cancer in the Australian population: identifying opportunities for intervention. ANZ J Surg 2020; 90: 2219-2226.","journal-title":"ANZ J Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"217350","DOI":"10.1016\/j.canlet.2024.217350","article-title":"Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy","volume":"610","author":"Yu","year":"2025","unstructured":"Yu B, Shao S and Ma W. Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy. Cancer Lett 2025; 610: 217350.","journal-title":"Cancer Lett"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/PPO.0000000000000647","article-title":"The gut microbiome and pancreatic cancer development and treatment","volume":"29","author":"Attebury","year":"2023","unstructured":"Attebury H and Daley D. The gut microbiome and pancreatic cancer development and treatment. Cancer J 2023; 29: 49-56.","journal-title":"Cancer J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"216696","DOI":"10.1016\/j.canlet.2024.216696","article-title":"Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy","volume":"587","author":"Chen","year":"2024","unstructured":"Chen L, Xing X, Zhu Y, Chen Y, Pei H, Song Q, Li J and Zhang P. Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy. Cancer Lett 2024; 587: 216696.","journal-title":"Cancer Lett"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12029-022-00821-3","article-title":"Economic burden of pancreatic cancer in Europe: a literature review","volume":"54","author":"Hernandez","year":"2023","unstructured":"Hernandez D, Wagner F, Hernandez-Villafuerte K and Schlander M. Economic burden of pancreatic cancer in Europe: a literature review. J Gastrointest Cancer 2023; 54: 391-407.","journal-title":"J Gastrointest Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.amjmed.2020.11.009","article-title":"Contemporary management of pancreatic cancer from an internist perspective","volume":"134","author":"QUAR","year":"2021","unstructured":"Sipra QUAR, Islam M, Riaz IB, Zhaohui J, Babiker HM, Bekaii-Saab TS and Sonbol MB. Contemporary management of pancreatic cancer from an internist perspective. Am J Med 2021; 134: 576-586.","journal-title":"Am J Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s11684-023-1050-6","article-title":"Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges","volume":"17","author":"Jiang","year":"2023","unstructured":"Jiang Z, Zheng X, Li M and Liu M. Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges. Front Med 2023; 17: 1135-1169.","journal-title":"Front Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"104262","DOI":"10.1016\/j.critrevonc.2024.104262","article-title":"Microbiomes in pancreatic cancer can be an accomplice or a weapon","volume":"194","author":"Guo","year":"2024","unstructured":"Guo X, Wang P, Li Y, Chang Y and Wang X. Microbiomes in pancreatic cancer can be an accomplice or a weapon. Crit Rev Oncol Hematol 2024; 194: 104262.","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41575-021-00470-0","article-title":"Early detection of pancreatic cancer using DNA-based molecular approaches","volume":"18","author":"Singhi","year":"2021","unstructured":"Singhi AD and Wood LD. Early detection of pancreatic cancer using DNA-based molecular approaches. Nat Rev Gastroenterol Hepatol 2021; 18: 457-468.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"15906","DOI":"10.3390\/ijms242115906","article-title":"Therapeutic strategies for pancreatic-cancer-related type 2 diabetes centered around natural products","volume":"24","author":"Park","year":"2023","unstructured":"Park MN. Therapeutic strategies for pancreatic-cancer-related type 2 diabetes centered around natural products. Int J Mol Sci 2023; 24: 15906.","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/oncolo\/oyad080","article-title":"Management of patients with pancreatic cancer using the “right track” model","volume":"28","author":"Rosenzweig","year":"2023","unstructured":"Rosenzweig A, Berlin J, Chari S, Kindler H, Matrisian L, Mayoral A, Mills J, Nissen N, Picozzi V, Zelada-Arenas F and Fleming J. Management of patients with pancreatic cancer using the “right track” model. Oncologist 2023; 28: 584-595.","journal-title":"Oncologist"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"116492","DOI":"10.1016\/j.bcp.2024.116492","article-title":"Overcoming therapy resistance in pancreatic cancer: new insights and future directions","volume":"229","author":"Espona-Fiedler","year":"2024","unstructured":"Espona-Fiedler M, Patthey C, Lindblad S, Sarro I and Ohlund D. Overcoming therapy resistance in pancreatic cancer: new insights and future directions. Biochem Pharmacol 2024; 229: 116492.","journal-title":"Biochem Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Papadakos SP, Dedes N, Pergaris A, Gazouli M and Theocharis S. Exosomes in the treatment of pancreatic cancer: a moonshot to PDAC treatment? Int J Mol Sci 2022; 23: 3620.","DOI":"10.3390\/ijms23073620"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"103996","DOI":"10.1016\/j.ebiom.2022.103996","article-title":"Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer","volume":"79","author":"Truong","year":"2022","unstructured":"Truong E, Pandol S and Jeon C. Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer. EBioMedicine 2022; 79: 103996.","journal-title":"EBioMedicine"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.3748\/wjg.v28.i31.4235","article-title":"Early diagnosis of pancreatic cancer: what strategies to avoid a foretold catastrophe","volume":"28","author":"Tonini","year":"2022","unstructured":"Tonini V and Zanni M. Early diagnosis of pancreatic cancer: what strategies to avoid a foretold catastrophe. World J Gastroenterol 2022; 28: 4235-4248.","journal-title":"World J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.3390\/ijms25073914","article-title":"MicroRNAs in pancreatic cancer: advances in biomarker discovery and therapeutic implications","volume":"25","author":"Madadjim","year":"2024","unstructured":"Madadjim R, An T and Cui J. MicroRNAs in pancreatic cancer: advances in biomarker discovery and therapeutic implications. Int J Mol Sci 2024; 25: 3914.","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/MOG.0000000000000763","article-title":"Diabetes and pancreatic cancer: recent insights with implications for early diagnosis, treatment and prevention","volume":"37","author":"BU","year":"2021","unstructured":"Wu BU. Diabetes and pancreatic cancer: recent insights with implications for early diagnosis, treatment and prevention. Curr Opin Gastroenterol 2021; 37: 539-543.","journal-title":"Curr Opin Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s12276-024-01378-w","article-title":"Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology","volume":"57","author":"Xu","year":"2025","unstructured":"Xu J, Pham MD, Corbo V, Ponz-Sarvise M, Oni T, Ohlund D and Hwang CI. Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology. Exp Mol Med 2025; 57: 50-58.","journal-title":"Exp Mol Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1408770","DOI":"10.3389\/fimmu.2024.1408770","article-title":"Gut microbiota and pancreatic cancer risk, and the mediating role of immune cells and inflammatory cytokines: a Mendelian randomization study","volume":"15","author":"Chen","year":"2024","unstructured":"Chen Z, Wang Z, Bao H and Ma S. Gut microbiota and pancreatic cancer risk, and the mediating role of immune cells and inflammatory cytokines: a Mendelian randomization study. Front Immunol 2024; 15: 1408770.","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"10279","DOI":"10.1111\/jcmm.15684","article-title":"Mucins in pancreatic cancer: a well-established but promising family for diagnosis, prognosis and therapy","volume":"24","author":"Wang","year":"2020","unstructured":"Wang S, You L, Dai M and Zhao Y. Mucins in pancreatic cancer: a well-established but promising family for diagnosis, prognosis and therapy. J Cell Mol Med 2020; 24: 10279-10289.","journal-title":"J Cell Mol Med"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/8\/ajtr0165892.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:58:22Z","timestamp":1766023102000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/8\/ajtr0165892.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/ttqj2494","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}